September 20, 2019
House Speaker Nancy Pelosi (D-CA) introduced a measure that would empower the government to annually negotiate with manufacturers the prices for 250 brand-name prescription drugs and require manufacturers to offer the negotiated prices to employer group health plans and individual plans.
A summary of H.R. 3 says the bill would:
Outlook: Although the plan may be able to pass the House and some GOP Senators have indicated they would be open to empowering Medicare to negotiate prices, the Trump administration has been supportive of a bipartisan bill that passed the Senate Finance Committee in July. Moreover, 9 of the 15 GOP committee members in the Senate voted against the bill, which will discourage Senate Majority Leader Mitch McConnell (R-KY) from bringing the bill up for a vote unless substantial changes are made to that legislation. President Trump, however, indicated support for a bipartisan effort in welcoming Speaker Pelosi's measure via tweet.